3-121993364-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_001199799.2(ILDR1):c.1385G>A(p.Arg462Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000197 in 1,610,130 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001199799.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 42Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152186Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000141 AC: 35AN: 248530 AF XY: 0.000149 show subpopulations
GnomAD4 exome AF: 0.000199 AC: 290AN: 1457826Hom.: 2 Cov.: 41 AF XY: 0.000190 AC XY: 138AN XY: 724418 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000177 AC: 27AN: 152304Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74474 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Arg462Gln variant in ILDR1 has now been identified by our laboratory in th ree individuals with hearing loss, none of whom had a variant affecting the rema ining copy of the gene. This variant has also been identified in 8/64714 Europea n chromosomes and 6/8534 East Asian chromosomes by the Exome Aggregation Consort ium (ExAC, http://exac.broadinstitute.org; dbSNP rs200630651). Although this var iant has been seen in the general population, its frequency is not high enough t o rule out a pathogenic role. Computational prediction tools and conservation an alyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Arg462Gln variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.1385G>A (p.R462Q) alteration is located in exon 7 (coding exon 7) of the ILDR1 gene. This alteration results from a G to A substitution at nucleotide position 1385, causing the arginine (R) at amino acid position 462 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at